Skip to main content
Clinical Trials/IRCT2015090923963N1
IRCT2015090923963N1
Completed
Phase 2

Effect of Antenatal Steroid before Elective Cesarean Section(C/S) on Prevention of Respiratory Morbidity of Term Neonates.

Vice chancellor for research, Babol University of Medical Sciences0 sites100 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Respiratory distress of newborn.
Sponsor
Vice chancellor for research, Babol University of Medical Sciences
Enrollment
100
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Babol University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria for the mothers; gestational age \=39 weeks (based on ultrasound examination) and maternal cesarean section indications only because of repetitive C/S.
  • Exclusion criteria for the mothers; mothers with premature delivery, infection, diabetes, premature rupture of membranes and the use of steroids before birth and also C/s because of other reasons( other than the repeated C/S, such as medical or obstetric underlying disease, for example cephalopelvic disproportion, retinal detachment, and macrosomia. Inclusion criteria for neonates; All infants with gestational age of \=39 weeks (which is based on ultrasound examination and also by the researcher’s physical examination after birth by the New Ballard Scoring system.).
  • Exclusion criteria for neonates; Underlying diseases such as IUGR, macrosomia , perinatal infection, congenital anomalies (Congenital heart diseases, etc.).

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials